p53 Unleashes Endogenous Retroviruses to Tackle Tumors: Study
p53 Unleashes Endogenous Retroviruses to Tackle Tumors: Study
New experiments suggest the famous tumor-suppressing protein uses viral elements lingering in the genome to get cancerous cells to announce their presence to the immune system.
p53 Unleashes Endogenous Retroviruses to Tackle Tumors: Study
p53 Unleashes Endogenous Retroviruses to Tackle Tumors: Study

New experiments suggest the famous tumor-suppressing protein uses viral elements lingering in the genome to get cancerous cells to announce their presence to the immune system.

New experiments suggest the famous tumor-suppressing protein uses viral elements lingering in the genome to get cancerous cells to announce their presence to the immune system.

cancer
A Guide to Biobank Storage
A Guide to Biobank Storage
Thermo Fisher Scientific | Jul 29, 2021
Choose the right temperature and storage product for each type of specimen.
How Laboratory Testing Supports Clinical Trials
How Laboratory Testing Supports Clinical Trials
Canopy Biosciences | Jul 23, 2021
Explore the importance of histology and biomarker evaluation for oncology clinical trials.
Optical Genome Mapping Works Well in Detecting Cancer Risk
Optical Genome Mapping Works Well in Detecting Cancer Risk
Marcus A. Banks | Jul 22, 2021
The relatively new technique for visually detecting chromosomal variants associated with disease risk performs at least as well as more established techniques in two recent studies.
Hawai‘i Legislature Terminates Tenured Professor’s Position
Hawai‘i Legislature Terminates Tenured Professor’s Position
Christie Wilcox | Jul 21, 2021
Thanks to administrative shuffling, professor Carl-Wilhelm Vogel remains employed at the University of Hawai‘i despite the removal of his position in the new state budget, but the university’s faculty union says lawmakers might have crossed a legal line.
Australian Research Faces Impending Scarcity of Lab Rodents
Australian Research Faces Impending Scarcity of Lab Rodents
Bianca Nogrady | Jul 20, 2021
The Australian biomedical research community is stunned by the announced wind-down of the country’s biggest supplier of mice and rats.
Undone Proteins Take Out Bladder Cancer
Undone Proteins Take Out Bladder Cancer
Roni Dengler, PhD | Jul 20, 2021
An unfolded protein found in human milk shows promise in early clinical trials to treat bladder cancer.
Homing Technology Delivers Therapy to Cancerous Bone
Homing Technology Delivers Therapy to Cancerous Bone
Roni Dengler, PhD | Jul 19, 2021
A clever approach to modifying already existing cancer therapies may be a game changer for treating metastatic breast cancer.
Analyzing Biological Systems with Flow Cytometry
Analyzing Biological Systems with Flow Cytometry
The Scientist Creative Services Team in collaboration with Beckman Coulter Life Sciences | Jul 19, 2021
Single-cell analysis provides a superior view of heterogeneous cell populations.
Cross-Resistance: One Cancer Therapy Can Undermine the Next
Cross-Resistance: One Cancer Therapy Can Undermine the Next
Sophie Fessl | Jul 16, 2021
Targeted cancer therapy may jeopardize the effectiveness of subsequent immunotherapy by reducing dendritic cell numbers and activation, according to study of mice and patient samples.
Antibiotic-Linked Antibody Attacks Cancer’s Sinister Neighbor Cells
Antibiotic-Linked Antibody Attacks Cancer’s Sinister Neighbor Cells
Roni Dengler, PhD | Jul 14, 2021
An unexpected and unprecedented finding may lead to improved cancer therapies.
Human Blood Harbors Cell-Free Microbial DNA
Human Blood Harbors Cell-Free Microbial DNA
Abby Olena | Jul 9, 2021
After controlling for high levels of bacterial contamination in their lab and reagents, researchers detect microbial genetic material in plasma samples from healthy people and cancer patients.
Enhancing the Efficacy of CAR-T Cell Therapies
Enhancing the Efficacy of CAR-T Cell Therapies
The Scientist Creative Services Team in Collaboration with IsoPlexis | Jun 29, 2021
Jessica Morris will discuss strategies to improve CAR-T cell targeting, activation, and killing capabilities.
COVID-19 Vaccines Work in People with Cancer: Study
COVID-19 Vaccines Work in People with Cancer: Study
Marcus A. Banks | Jun 25, 2021
Moderna’s, Pfizer’s, and Johnson & Johnson’s shots all offered protection against the virus regardless of cancer type, although slightly less so in people with blood cancer.
Improving Cancer Immunotherapy with Anti-Cancer Adenoviruses
Improving Cancer Immunotherapy with Anti-Cancer Adenoviruses
The Scientist Creative Services Team in Collaboration with IsoPlexis | Jun 25, 2021
Researchers use a mesenchymal stromal cell-based vector to deliver multiple viruses simultaneously to improve CAR-T cell anti-tumor activity.
“Lemon Frost” Leopard Geckos’ Cancers Similar to Human Melanomas
“Lemon Frost” Leopard Geckos’ Cancers Similar to Human Melanomas
Christie Wilcox | Jun 24, 2021
The color morph’s bright yellow hue and its propensity for skin tumors both likely stem from a gene implicated in a dangerous form of human skin cancer, suggesting the animals could make an ideal model for studying the disease.
John Pawelek, Who Explored the Causes of Metastasis, Dies at 79
John Pawelek, Who Explored the Causes of Metastasis, Dies at 79
Marcus A. Banks | Jun 22, 2021
The Yale School of Medicine cancer researcher doggedly pursued the question of how cancer spreads.
Cancer Metastasizes Via Fusion of Tumor and Immune Cells: Study
Cancer Metastasizes Via Fusion of Tumor and Immune Cells: Study
Marcus A. Banks | Jun 17, 2021
Researchers say evidence of hybridization between leukocytes and cancer indicates that this is a primary means of metastasis. Others disagree.
Deadly Facial Tumors Spur Tasmanian Devil Evolution: Study
Deadly Facial Tumors Spur Tasmanian Devil Evolution: Study
Christie Wilcox | Jun 16, 2021
The largest study to date of the animals’ genetics provides robust evidence that they are adapting to survive a highly lethal, contagious cancer scientists feared would cause their extinction.
Introducing Cell Culture Application-Specific Fetal Bovine Serum Products
Introducing Cell Culture Application-Specific Fetal Bovine Serum Products
The Scientist Creative Services Team in collaboration with MilliporeSigma | Jun 15, 2021
A cost-effective fetal bovine serum product line is tailored for individual cell culture needs.